Back to Search Start Over

Biological function and research progress of N6-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers.

Authors :
Yue Wu
An Li
Can Chen
Zhang Fang
Lujun Chen
Xiao Zheng
Source :
Frontiers in Oncology; 2023, p1-10, 10p
Publication Year :
2023

Abstract

N<superscript>6</superscript>-methyladenosine (m<superscript>6</superscript>A) is the most prevalent internal modification found in both mRNA and lncRNA. It exerts reversible regulation over RNA function and affects RNA processing and metabolism in various diseases, especially tumors. The m<superscript>6</superscript>A binding protein, hnRNPA2B1, is extensively studied as a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) protein family. It is frequently dysregulated and holds significant importance in multiple types of tumors. By recognizing m<superscript>6</superscript>A sites for variable splicing, maintaining RNA stability, and regulating translation and transport, hnRNPA2B1 plays a vital role in various aspects of tumor development, metabolism, and regulation of the immune microenvironment. In this review, we summarized the latest research on the functional roles and underlying molecular mechanisms of hnRNPA2B1. Moreover, we discussed its potential as a target for tumor therapy. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
2234943X
Database :
Complementary Index
Journal :
Frontiers in Oncology
Publication Type :
Academic Journal
Accession number :
169932947
Full Text :
https://doi.org/10.3389/fonc.2023.1229168